FI923758A0 - Expressionssystem. - Google Patents

Expressionssystem.

Info

Publication number
FI923758A0
FI923758A0 FI923758A FI923758A FI923758A0 FI 923758 A0 FI923758 A0 FI 923758A0 FI 923758 A FI923758 A FI 923758A FI 923758 A FI923758 A FI 923758A FI 923758 A0 FI923758 A0 FI 923758A0
Authority
FI
Finland
Prior art keywords
expression systems
desired polypeptide
cdna
vector
sequence
Prior art date
Application number
FI923758A
Other languages
English (en)
Other versions
FI923758A (fi
Inventor
Melwyn Hollis
Maurice Ronald Charles Needham
Clare Gooding
Franklin Geradus Grosveld
Michael Antoniou
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of FI923758A0 publication Critical patent/FI923758A0/fi
Publication of FI923758A publication Critical patent/FI923758A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Massaging Devices (AREA)
FI923758A 1990-12-21 1992-08-20 Expressionssystem FI923758A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909027917A GB9027917D0 (en) 1990-12-21 1990-12-21 Expression systems
PCT/GB1991/002274 WO1992011380A1 (en) 1990-12-21 1991-12-19 Expression systems

Publications (2)

Publication Number Publication Date
FI923758A0 true FI923758A0 (fi) 1992-08-20
FI923758A FI923758A (fi) 1992-08-20

Family

ID=10687512

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923758A FI923758A (fi) 1990-12-21 1992-08-20 Expressionssystem

Country Status (18)

Country Link
US (1) US5538885A (fi)
EP (1) EP0516787B1 (fi)
JP (1) JP3148237B2 (fi)
KR (1) KR920703830A (fi)
AT (1) ATE196653T1 (fi)
AU (1) AU660636B2 (fi)
CA (1) CA2058280A1 (fi)
CS (1) CS267192A3 (fi)
DE (1) DE69132429T2 (fi)
FI (1) FI923758A (fi)
GB (2) GB9027917D0 (fi)
HU (1) HUT66062A (fi)
IE (1) IE914497A1 (fi)
IL (1) IL100413A0 (fi)
NZ (1) NZ241045A (fi)
PL (1) PL295798A1 (fi)
WO (1) WO1992011380A1 (fi)
ZA (1) ZA9110015B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627268A (en) * 1994-06-07 1997-05-06 Dnx Biotherapeutics Hemoglobin comprising globin fusion proteins
US5821351A (en) * 1994-06-10 1998-10-13 Dnx Biotherapeutics Production of hemoglobin having a delta-like globin
GB9505777D0 (en) * 1995-03-22 1995-05-10 Zeneca Ltd Process
ATE199570T1 (de) * 1996-08-16 2001-03-15 Medical Res Council Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
US6284496B1 (en) 1997-10-03 2001-09-04 University Of South Florida DNA vector for determining the presence of out-of-reading-frame mutations
CN1159455C (zh) * 1998-06-08 2004-07-28 Acgt医药公司 Dna,rna和蛋白的检测
GB9910664D0 (en) * 1999-05-07 1999-07-07 Zeneca Ltd Cells and assay
US6645745B1 (en) * 2000-05-30 2003-11-11 Epidauros Biotechnologie Ag Identification of a new member of the cytochrome P450 3A (CYP3A) gene family: CYP3AX
US7033806B2 (en) * 2000-06-08 2006-04-25 The Regents Of The University Of California HY2 family of bilin reductases
US7326549B2 (en) * 2001-03-19 2008-02-05 Cargill, Incorporated Myo-inositol oxygenases
US6887688B2 (en) * 2001-05-29 2005-05-03 The Regents Of The University Of California Light controlled gene expression utilizing heterologous phytochromes
US7473527B2 (en) * 2002-07-02 2009-01-06 The Uab Research Foundation Compounds promoting delivery of genes
US7795397B2 (en) * 2004-05-06 2010-09-14 The Regents Of The University Of California Red and near infrared flourescent phyotochrome
CN107106689A (zh) * 2014-11-05 2017-08-29 沃雅戈治疗公司 用于治疗帕金森病的aadc多核苷酸
EP3831281A1 (en) 2016-08-30 2021-06-09 The Regents of The University of California Methods for biomedical targeting and delivery and devices and systems for practicing the same
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
JP7229989B2 (ja) 2017-07-17 2023-02-28 ボイジャー セラピューティクス インコーポレイテッド 軌道アレイガイドシステム

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663281A (en) * 1984-03-22 1987-05-05 Mass Institute Of Technology Enhanced production of proteinaceous materials in eucaryotic cells
CA1297435C (en) * 1986-09-12 1992-03-17 Stephen D. Gillies Messenger rna stabilization in animal cells
DE3730599A1 (de) * 1986-09-12 1988-07-07 Genentech Inc Verfahren zur kontinuierlichen herstellung von heterologen proteinen in eukaryontischen wirtszellen
GB8718779D0 (en) 1987-08-07 1987-09-16 Grosveld F G Dna sequence & expression vector
JP2779192B2 (ja) * 1987-09-17 1998-07-23 マサチユセツツ・インスチチユート・オブ・テクノロジー ヒト赤血球特異的転写エンハンサー
GB8904009D0 (en) * 1989-02-22 1989-04-05 Celltech Ltd Vector
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc A method of producing a recombinant human necrotic factor absorber
WO1991005041A1 (en) * 1989-09-26 1991-04-18 Townes Tim M Erythroid-specific gene expression system
WO1991013151A1 (en) * 1990-02-22 1991-09-05 Biogen, Inc. Improved expression of polypeptides

Also Published As

Publication number Publication date
GB2251622A (en) 1992-07-15
EP0516787B1 (en) 2000-09-27
ZA9110015B (en) 1992-10-28
GB9027917D0 (en) 1991-02-13
CS267192A3 (en) 1992-12-16
GB2251622B (en) 1995-05-03
IL100413A0 (en) 1992-09-06
GB9126984D0 (en) 1992-02-19
KR920703830A (ko) 1992-12-18
FI923758A (fi) 1992-08-20
AU9096891A (en) 1992-07-22
EP0516787A1 (en) 1992-12-09
DE69132429D1 (de) 2000-11-02
NZ241045A (en) 1994-11-25
US5538885A (en) 1996-07-23
PL295798A1 (en) 1993-07-12
ATE196653T1 (de) 2000-10-15
AU660636B2 (en) 1995-07-06
CA2058280A1 (en) 1992-06-22
HUT66062A (en) 1994-09-28
IE914497A1 (en) 1992-07-01
HU9202458D0 (en) 1992-10-28
JP3148237B2 (ja) 2001-03-19
JPH05504261A (ja) 1993-07-08
WO1992011380A1 (en) 1992-07-09
DE69132429T2 (de) 2001-03-01

Similar Documents

Publication Publication Date Title
FI923758A (fi) Expressionssystem
DE69034179D1 (de) Expressionssysteme für ein amidierendes System
PT728214E (pt) Linhas celulares estaveis capazes de expressar o gene de replicacao do virus adeno-associado
EP0260148A3 (en) Improved recombinant expression method, vector and transformed cells
FI871144A (fi) Foerfarande foer framstaellning av proteinprodukter i aspegillus oryzae och en promotor foer anvaendning i aspergillus.
AU2795292A (en) Synthetic dna sequence having enhanced insecticidal activity in maize
ES8302774A1 (es) Un metodo para producir un vector de clonacion mejorado.
WO1994003616A3 (fr) Vecteur de clonage et/ou de sequençage
IE822817L (en) Stabilization and selection of host cells containing¹recombinant dna
GB2147585B (en) Cdna clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity and/or mast cell growth factor activity
GB8625435D0 (en) Human apolipoprotein ai
AU3668389A (en) Exogenous gene expression vector containing chick beta-actin gene promoter
EP1040184A4 (en) $ I HIGH EXPRESSION VECTOR (ESCHERICHIA COLI)
DK0975775T3 (da) Regulatorisk system til inducerbar ekspression af gener med lambdapromotorer
ES8800353A1 (es) Procedimiento de clonacion de factor humano viii-r.
NO923271L (no) Ekspresjonssystemer
NO974713D0 (no) Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
DK1071798T3 (da) Konstruktioner til reguleret ekspression af rekombinante gener i prokaryote celler

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ZENECA LIMITED